Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

5-MTHF availability limits whole-body methylation throughput.

Insufficient 5-methyltetrahydrofolate reduces the methionine synthase reaction, creating a bottleneck that lowers global methylation capacity.

SupportedJune 19, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Folate, as 5-methyltetrahydrofolate (5-MTHF), donates the methyl group used by methionine synthase to convert homocysteine into methionine, so higher folate demand can bottleneck methylation throughput.

laying out figure…
All 9 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that 5-MTHF supplies the methyl group used by methionine synthase to convert homocysteine into methionine, so low folate availability mechanically constrains the methionine–SAM regeneration pathway. The mechanism graph frames this as a rate-limiting step: reduced 5-MTHF lowers methionine and SAM production while allowing SAH to accumulate, which together reduce overall methylation throughput. Restoring 5-MTHF availability reverses this bottleneck in the described pathway model.

Verified conclusion

The metabolic relationship between folate status and methylation efficiency is a cornerstone of biochemical health. Evidence confirms that the availability of specific folate metabolites acts as a primary controller for the body's global methylation capacity.

Clinical and metabolic evidence

Research consistently identifies folate availability as a rate-limiting factor for methylation throughput. The system's efficiency is typically measured by the S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) ratio, often referred to as the "methylation index."

  • Bottleneck mechanism: When folate demand exceeds supply, SAM production decreases while SAH—a potent inhibitor of most methyltransferase enzymes—accumulates. This imbalance directly reduces the throughput of hundreds of essential methylation reactions, including those responsible for DNA regulation and neurotransmitter synthesis.
  • Clinical impact: Studies on the MTHFR C677T polymorphism, which effectively increases folate demand by reducing recycling efficiency, show that individuals with lower folate availability exhibit significantly lower global DNA methylation. Supplementation with 5-MTHF has been shown to restore these methylation ratios, bypass the "folate trap," and normalize homocysteine levels.

Mechanistic explanations

The claim is rooted in the direct catalytic requirements of the methionine cycle, where folate functions as the master methyl donor.

  • Methyl transfer chemistry: 5-methyltetrahydrofolate (5-MTHF) serves as the methyl donor for the enzyme methionine synthase (MTR). This enzyme utilizes a cobalamin (vitamin B12) cofactor to physically transport the C5-methyl group from 5-MTHF to homocysteine.
  • Remethylation pathway: This reaction converts homocysteine into methionine, which is then activated into SAM. Because this is the primary pathway for regenerating the body's universal methyl donor, any insufficiency in 5-MTHF creates a mechanical bottleneck that restricts the entire transmethylation system.

Bottom line

The claim is fully supported: 5-MTHF is the essential methyl donor for converting homocysteine to methionine, and insufficient folate availability creates a functional bottleneck that reduces global methylation throughput.

References

  1. Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling — linkinghub.elsevier.com ↗
  2. The role of methionine synthases in fungal metabolism and virulence. — portlandpress.com ↗
  3. Abstract 3803: CRISPR screening identifies methionine synthase as a potential therapeutic target in KRAS-driven NSCLC — aacrjournals.org ↗
  4. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. — linkinghub.elsevier.com ↗
  5. One carbon metabolism and early development: a diet-dependent destiny — pmc.ncbi.nlm.nih.gov ↗
  6. Homocystinuria diagnosis and management: it is not all classical — jcp.bmj.com ↗
  7. Methionine synthase supports tumor tetrahydrofolate pools — pmc.ncbi.nlm.nih.gov ↗
  8. Human B12-dependent enzymes: Methionine synthase and Methylmalonyl-CoA mutase. — pmc.ncbi.nlm.nih.gov ↗
  9. Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles — mdpi.com ↗
  10. Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. — pmc.ncbi.nlm.nih.gov ↗
  11. The relationship between intracellular and plasma levels of folate and metabolites in the methionine cycle: a model. — pmc.ncbi.nlm.nih.gov ↗
  12. Neural tube defects induced by folate deficiency in mutant curly tail (Grhl3) embryos are associated with alteration in folate one-carbon metabolism but are unlikely to result from diminished methylation. — pmc.ncbi.nlm.nih.gov ↗
  13. Association of Folate and Vitamins Involved in the 1-Carbon Cycle with Polymorphisms in the Methylenetetrahydrofolate Reductase Gene (MTHFR) and Global DNA Methylation in Patients with Colorectal Cancer — mdpi.com ↗
  14. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→